Core Scientific, Inc./tx
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $1.05B | $2.44B | $117.9M |
| FY2022 | $1.22B | $807.7M | $15.9M |
| FY2023 | $1.31B | $712.2M | $50.4M |
| FY2024 | $2.42B | $664.2M | $836.2M |
| FY2025 | $3.31B | $2.35B | $311.4M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $1.05B | $2.44B | $117.9M |
| FY2022 | $1.22B | $807.7M | $15.9M |
| FY2023 | $1.31B | $712.2M | $50.4M |
| FY2024 | $2.42B | $664.2M | $836.2M |
| FY2025 | $3.31B | $2.35B | $311.4M |